This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Veterinary Auto-Immune Therapeutics Market

Veterinary Auto-immune Therapeutics are Gaining Strength. Know the Key Highlights

Veterinary auto-immune Therapeutics Market by Therapy Type, Disease Indication, Animal Type, Distribution Channel & Region | Forecast 2022 to 2032.

Veterinary Auto-Immune Therapeutics Market Outlook (2022 to 2032)

The global veterinary auto-immune therapeutics market is projected to be appraised at US$ 69010.77293 million by 2032, up from US$ 41087.71686 million in 2022, advancing at a CAGR of 5.3% from 2022 to 2032.

The adoption of veterinary auto-immune therapeutics is on the surge as several new ways of treating autoimmune diseases in animals using various drugs and other therapies like surgeries and stem cell therapies are evolving worldwide.

The demand for these drugs also rises as used to reduce the symptoms associated with the specific autoimmune disease. Furthermore, auto-immune disease treatment is gaining more attention owing to an increased threat of zoonotic disease transfer among humans, in turn positively impacting the veterinary auto-immune therapeutics market outlook.

Hence, the growing incidence of zoonotic disease transfer is changing business operations of the animal healthcare industry as emergency care.

Report Attribute

Details

Veterinary auto-immune therapeutics Market Value (2022)

US$ 41087.71686 Million

Veterinary auto-immune therapeutics Market Anticipated Forecast Value (2032)

US$ 69010.77293 Million

Veterinary auto-immune therapeutics Market Projected Growth Rate (2022 to 2032)

5.3%

The veterinary auto-immune therapeutics market growth is fuelled by veterinary hospitals as they are offering a wide range of therapeutic services for companion animals. An increase in the prevalence of autoimmune illness and a rise in Research and Development efforts to provide the best possible treatments in tandem with a surge in the use of therapeutics for the condition are also anticipated to contribute to the market growth in coming years.

Moreover, the market is expanded by the rise in autoimmune disease incidence and early illness detection, and the recent introduction of cutting-edge therapies during the forecast period. A significant number of late-stage pipeline medications are also present, including tocilizumab, certolizumab, baricitinib, etanercept, secukinumab, elotuzumab, abatacept, PF-06438179, apremilast, golimumab, certolizumab, ustekinumab, tofacitinib, and others.

The increasing transfer of zoonotic diseases among immunosuppressed patients is a prime factor responsible for the rising awareness of the auto-immune disease among companion animals.

Customize this Report

Let us know your requirement to get
100% FREE customization

What Are The Key Veterinary Auto-Immune Therapeutics Market?

The high threat of HIV transfer from the animal source to a person with suppressed immunity, and the transfer of allergic components from companion animals to family members are also spiking the demand for veterinary auto-immune therapeutics.

The growing incidence of autoimmune diseases in livestock animals has decreased the quality of meat consumed especially in pharmaceutical manufacturing. Moreover, the focus on livestock health among African countries which are the main exporters of livestock is further surging the demand for autoimmune disease therapy.

However, limited therapy options for animals in developing countries and a lack of awareness are hindering the growth of the veterinary auto-immune therapeutics market.

Why Is North America Likely To Lead The Veterinary Auto-Immune Therapeutics Market?

Due to numerous government-sponsored programs that promote these diagnostic tests, North America holds the largest market share in the world for the diagnosis of animal auto-immune diseases accounting for 29% in 2022. The increased demand for all healthcare improvements for animal welfare is a result of the region's increased meat consumption.

There is a huge knowledge of the effects and impacts of auto-immune disorders thanks to their prevalence, in turn expanding the veterinary auto-immune therapeutics market size.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What Is The Growth Outlook For The Europe Veterinary Auto-Immune Therapeutics Market?

Europe is likely to get hold of the veterinary auto-immune therapeutics market share of 22.9% in 2022. The main factor driving rising utilization rates is the increased awareness of animal autoimmune diseases brought on by programs in research, support, advocacy, and education.

The European Commission is pursuing a number of initiatives to rise public knowledge of the factors that may contribute to the onset of animal auto-immune diseases, thereby spurring the adoption of such therapeutics.

How Is The Start-up Ecosystem In The Veterinary Auto-Immune Therapeutics Market?

A Med City biotech company received more than $330,000 in federal money to explore gene therapy for dogs and possibly people in the future. The National Institutes of Health has given a $337,443 Phase I Small Business Innovation Research grant to Life Engine Animal Health, or LEAH Labs, led by CEO and co-founder Dr. Wes Wierson.

With assistance from the Mayo Clinic, Wierson developed gene editing methods that are used by LEAH Labs. The Mayo Clinic granted a license to LEAH Labs for the study. Downtown Rochester is where LEAH Labs is headquartered.

In the second quarter of 2022, pilot tests for the start-up's first product, a CAR-T cell therapy for cancerous dogs, are anticipated to begin. The objective is to develop a treatment for canine B cell lymphoma malignancy. An estimated 300,000 canines every year succumb to that form of cancer, which is analogous to Non-lymphoma Hodgkin's in people.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

What Is The Competition Landscape In The Veterinary Auto-Immune Therapeutics Market?

Market players are employing various organic and inorganic strategies including mergers & acquisitions, partnerships, collaborations, etc. in order to consolidate their position in the veterinary auto-immune therapeutics market.

A few of the recent developments in the veterinary auto-immune therapeutics market are:

  • Leading provider of life science solutions QIAGEN N.V. was purchased by Thermo Fisher Scientific Inc. They operate in 25 nations and offer diagnostic solutions for all geographical areas.
  • A unique blood test that displays the risk index of autoimmune illnesses was introduced by Progentec. In 12 weeks, it can evaluate the propensity for systemic lupus erythematosus.

Key players

  • Aratana Therapeutics Inc.
  • Pfizer Inc.
  • Vet-Stem, Inc.
  • Ambrx Inc.
  • Taconic Biosciences, Inc.
  • JBS United
  • Virbac
  • Eli Lilly and Company
  • Jaguar Animal Health Inc.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 5.3% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2016 to 2021

Forecast Period

2022 to 2032

Quantitative Units

Revenue in USD Million and CAGR from 2022 to 2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis

Segments Covered

  • Therapy Type
  • Disease Indication
  • Animal Type
  • Distribution Channel
  • Region

Regions Covered

  • North America
  • Latin America
  • The Asia Pacific
  • Middle East and Africa
  • Europe

Key Countries Profiled

  • United States of America
  • Canada
  • Brazil
  • Argentina
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • ASIAN
  • GCC Countries
  • South Africa

Key Companies Profiled

  • Aratana Therapeutics Inc.
  • Pfizer Inc.
  • Vet-Stem, Inc.
  • Ambrx Inc.
  • Taconic Biosciences, Inc.
  • JBS United
  • Virbac
  • Eli Lilly and Company
  • Jaguar Animal Health Inc.

Customization

Available Upon Request

Key Segments Profiled In The Veterinary Auto-Immune Therapeutics Market Survey

By Therapy Type:

  • Corticosteroids, Azathioprine
  • Cyclosporine
  • Mycophenolate
  • Leflunomide
  • Cyclophosphamide
  • Levothyroxine
  • Folic Acid
  • Hydroxychloroquine
  • Chloroquine

By Disease Indication:

  • Hypothyroidism
  • Pemphigus Disease
  • Canine Lupus
  • Auto-Immune Hemolytic Anemia
  • Bullous Pemphigoid
  • Discoid Lupus Erythematosus (DLE)
  • Immune-related arthritis
  • Others

By Animal Type:

  • Companion Animal
  • Dogs
  • Cats
  • Horse
  • Live Stock Animal
  • Cattle
  • Swine
  • Poultry
  • Fish
  • Sheep

By Distribution Channel:

  • Veterinary Hospitals
  • Veterinary Clinics

By Region:

  • North America
  • Latin America
  • The Asia Pacific
  • Middle East and Africa
  • Europe

Frequently Asked Questions

The veterinary auto-immune therapeutics market is projected to move ahead with a 5.3% CAGR (2022 to 2032).

North America is anticipated to hold a major veterinary auto-immune therapeutics market share.

The veterinary auto-immune therapeutics market is anticipated account for US$ 69010.77293 million by 2032.

Table of Content

1. Executive Summary | Veterinary Auto-Immune Therapeutics Market 

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032

    4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Therapy Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Therapy Type, 2017 to 2021

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Therapy Type, 2022 to 2032

        5.3.1. Corticosteroids

        5.3.2. Azathioprine

        5.3.3. Cyclosporine

        5.3.4. Mycophenolate

        5.3.5. Leflunomide

        5.3.6. Cyclophosphamide

        5.3.7. Levothyroxine

        5.3.8. Folic Acid

        5.3.9. Hydroxychloroquine

        5.3.10. Chloroquine

    5.4. Y-o-Y Growth Trend Analysis By Therapy Type, 2017 to 2021

    5.5. Absolute $ Opportunity Analysis By Therapy Type, 2022 to 2032

6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Disease Indication

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Disease Indication, 2017 to 2021

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Disease Indication, 2022 to 2032

        6.3.1. Hypothyroidism

        6.3.2. Pemphigus Disease

        6.3.3. Canine Lupus

        6.3.4. Auto-Immune Hemolytic Anemia

        6.3.5. Bullous Pemphigoid

        6.3.6. Discoid Lupus Erythematosus (DLE)

        6.3.7. Immune-related arthritis

        6.3.8. Others

    6.4. Y-o-Y Growth Trend Analysis By Disease Indication, 2017 to 2021

    6.5. Absolute $ Opportunity Analysis By Disease Indication, 2022 to 2032

7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Animal Type

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By Animal Type, 2017 to 2021

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Animal Type, 2022 to 2032

        7.3.1. Companion Animal

        7.3.2. Dogs

        7.3.3. Cats

        7.3.4. Horse

        7.3.5. Live Stock Animal

        7.3.6. Cattle

        7.3.7. Swine

        7.3.8. Poultry

        7.3.9. Fish

        7.3.10. Sheep

    7.4. Y-o-Y Growth Trend Analysis By Animal Type, 2017 to 2021

    7.5. Absolute $ Opportunity Analysis By Animal Type, 2022 to 2032

8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channel Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel Type, 2017 to 2021

    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel Type, 2022 to 2032

        8.3.1. Veterinary Hospitals

        8.3.2. Veterinary Clinics

    8.4. Y-o-Y Growth Trend Analysis By Distribution Channel Type, 2017 to 2021

    8.5. Absolute $ Opportunity Analysis By Distribution Channel Type, 2022 to 2032

9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021

    9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. Asia Pacific

        9.3.5. Middle East and Africa

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        10.2.1. By Country

            10.2.1.1. United States of America

            10.2.1.2. Canada

        10.2.2. By Therapy Type

        10.2.3. By Disease Indication

        10.2.4. By Animal Type

        10.2.5. By Distribution Channel Type

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Therapy Type

        10.3.3. By Disease Indication

        10.3.4. By Animal Type

        10.3.5. By Distribution Channel Type

    10.4. Key Takeaways

11. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Rest of Latin America

        11.2.2. By Therapy Type

        11.2.3. By Disease Indication

        11.2.4. By Animal Type

        11.2.5. By Distribution Channel Type

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Therapy Type

        11.3.3. By Disease Indication

        11.3.4. By Animal Type

        11.3.5. By Distribution Channel Type

    11.4. Key Takeaways

12. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. United Kingdom

            12.2.1.3. France

            12.2.1.4. Spain

            12.2.1.5. Italy

            12.2.1.6. Rest of Europe

        12.2.2. By Therapy Type

        12.2.3. By Disease Indication

        12.2.4. By Animal Type

        12.2.5. By Distribution Channel Type

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Therapy Type

        12.3.3. By Disease Indication

        12.3.4. By Animal Type

        12.3.5. By Distribution Channel Type

    12.4. Key Takeaways

13. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

            13.2.1.4. Malaysia

            13.2.1.5. Singapore

            13.2.1.6. Australia

            13.2.1.7. Rest of Asia Pacific

        13.2.2. By Therapy Type

        13.2.3. By Disease Indication

        13.2.4. By Animal Type

        13.2.5. By Distribution Channel Type

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Therapy Type

        13.3.3. By Disease Indication

        13.3.4. By Animal Type

        13.3.5. By Distribution Channel Type

    13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of Middle East and Africa

        14.2.2. By Therapy Type

        14.2.3. By Disease Indication

        14.2.4. By Animal Type

        14.2.5. By Distribution Channel Type

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Therapy Type

        14.3.3. By Disease Indication

        14.3.4. By Animal Type

        14.3.5. By Distribution Channel Type

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. United Kingdom

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2021

            15.1.2.1. By Therapy Type

            15.1.2.2. By Disease Indication

            15.1.2.3. By Animal Type

            15.1.2.4. By Distribution Channel Type

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2021

            15.2.2.1. By Therapy Type

            15.2.2.2. By Disease Indication

            15.2.2.3. By Animal Type

            15.2.2.4. By Distribution Channel Type

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2021

            15.3.2.1. By Therapy Type

            15.3.2.2. By Disease Indication

            15.3.2.3. By Animal Type

            15.3.2.4. By Distribution Channel Type

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2021

            15.4.2.1. By Therapy Type

            15.4.2.2. By Disease Indication

            15.4.2.3. By Animal Type

            15.4.2.4. By Distribution Channel Type

    15.5. Rest of Latin America

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2021

            15.5.2.1. By Therapy Type

            15.5.2.2. By Disease Indication

            15.5.2.3. By Animal Type

            15.5.2.4. By Distribution Channel Type

    15.6. Germany

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2021

            15.6.2.1. By Therapy Type

            15.6.2.2. By Disease Indication

            15.6.2.3. By Animal Type

            15.6.2.4. By Distribution Channel Type

    15.7. United Kingdom

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2021

            15.7.2.1. By Therapy Type

            15.7.2.2. By Disease Indication

            15.7.2.3. By Animal Type

            15.7.2.4. By Distribution Channel Type

    15.8. France

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2021

            15.8.2.1. By Therapy Type

            15.8.2.2. By Disease Indication

            15.8.2.3. By Animal Type

            15.8.2.4. By Distribution Channel Type

    15.9. Spain

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2021

            15.9.2.1. By Therapy Type

            15.9.2.2. By Disease Indication

            15.9.2.3. By Animal Type

            15.9.2.4. By Distribution Channel Type

    15.10. Italy

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2021

            15.10.2.1. By Therapy Type

            15.10.2.2. By Disease Indication

            15.10.2.3. By Animal Type

            15.10.2.4. By Distribution Channel Type

    15.11. Rest of Europe

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2021

            15.11.2.1. By Therapy Type

            15.11.2.2. By Disease Indication

            15.11.2.3. By Animal Type

            15.11.2.4. By Distribution Channel Type

    15.12. China

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2021

            15.12.2.1. By Therapy Type

            15.12.2.2. By Disease Indication

            15.12.2.3. By Animal Type

            15.12.2.4. By Distribution Channel Type

    15.13. Japan

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2021

            15.13.2.1. By Therapy Type

            15.13.2.2. By Disease Indication

            15.13.2.3. By Animal Type

            15.13.2.4. By Distribution Channel Type

    15.14. South Korea

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2021

            15.14.2.1. By Therapy Type

            15.14.2.2. By Disease Indication

            15.14.2.3. By Animal Type

            15.14.2.4. By Distribution Channel Type

    15.15. Malaysia

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2021

            15.15.2.1. By Therapy Type

            15.15.2.2. By Disease Indication

            15.15.2.3. By Animal Type

            15.15.2.4. By Distribution Channel Type

    15.16. Singapore

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2021

            15.16.2.1. By Therapy Type

            15.16.2.2. By Disease Indication

            15.16.2.3. By Animal Type

            15.16.2.4. By Distribution Channel Type

    15.17. Australia

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2021

            15.17.2.1. By Therapy Type

            15.17.2.2. By Disease Indication

            15.17.2.3. By Animal Type

            15.17.2.4. By Distribution Channel Type

    15.18. Rest of Asia Pacific

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2021

            15.18.2.1. By Therapy Type

            15.18.2.2. By Disease Indication

            15.18.2.3. By Animal Type

            15.18.2.4. By Distribution Channel Type

    15.19. GCC Countries

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2021

            15.19.2.1. By Therapy Type

            15.19.2.2. By Disease Indication

            15.19.2.3. By Animal Type

            15.19.2.4. By Distribution Channel Type

    15.20. South Africa

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2021

            15.20.2.1. By Therapy Type

            15.20.2.2. By Disease Indication

            15.20.2.3. By Animal Type

            15.20.2.4. By Distribution Channel Type

    15.21. Israel

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2021

            15.21.2.1. By Therapy Type

            15.21.2.2. By Disease Indication

            15.21.2.3. By Animal Type

            15.21.2.4. By Distribution Channel Type

    15.22. Rest of the Middle East and Africa

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2021

            15.22.2.1. By Therapy Type

            15.22.2.2. By Disease Indication

            15.22.2.3. By Animal Type

            15.22.2.4. By Distribution Channel Type

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Therapy Type

        16.3.3. By Disease Indication

        16.3.4. By Animal Type

        16.3.5. By Distribution Channel Type

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Aratana Therapeutics Inc

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. Pfizer Inc

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. Vet-Stem, Inc

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. Ambrx Inc

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. Taconic Biosciences, Inc

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. JBS Value (US$ Million)ed

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. Virbac

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. Eli Lilly

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. Jaguar Animal Health Inc

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology
Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Market Value (US$ Million) Forecast by Region, 2017 to 2032

Table 02: Global Market Value (US$ Million) Forecast by Therapy Type, 2017 to 2032

Table 03: Global Market Value (US$ Million) Forecast by Disease Indication, 2017 to 2032

Table 04: Global Market Value (US$ Million) Forecast by Animal Type, 2017 to 2032

Table 05: Global Market Value (US$ Million) Forecast by Distribution Channel Type, 2017 to 2032

Table 06: North America Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 07: North America Market Value (US$ Million) Forecast by Therapy Type, 2017 to 2032

Table 08: North America Market Value (US$ Million) Forecast by Disease Indication, 2017 to 2032

Table 09: North America Market Value (US$ Million) Forecast by Animal Type, 2017 to 2032

Table 10: North America Market Value (US$ Million) Forecast by Distribution Channel Type, 2017 to 2032

Table 11: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 12: Latin America Market Value (US$ Million) Forecast by Therapy Type, 2017 to 2032

Table 13: Latin America Market Value (US$ Million) Forecast by Disease Indication, 2017 to 2032

Table 14: Latin America Market Value (US$ Million) Forecast by Animal Type, 2017 to 2032

Table 15: Latin America Market Value (US$ Million) Forecast by Distribution Channel Type, 2017 to 2032

Table 16: Europe Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 17: Europe Market Value (US$ Million) Forecast by Therapy Type, 2017 to 2032

Table 18: Europe Market Value (US$ Million) Forecast by Disease Indication, 2017 to 2032

Table 19: Europe Market Value (US$ Million) Forecast by Animal Type, 2017 to 2032

Table 20: Europe Market Value (US$ Million) Forecast by Distribution Channel Type, 2017 to 2032

Table 21: Asia Pacific Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 22: Asia Pacific Market Value (US$ Million) Forecast by Therapy Type, 2017 to 2032

Table 23: Asia Pacific Market Value (US$ Million) Forecast by Disease Indication, 2017 to 2032

Table 24: Asia Pacific Market Value (US$ Million) Forecast by Animal Type, 2017 to 2032

Table 25: Asia Pacific Market Value (US$ Million) Forecast by Distribution Channel Type, 2017 to 2032

Table 26: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 27: Middle East and Africa Market Value (US$ Million) Forecast by Therapy Type, 2017 to 2032

Table 28: Middle East and Africa Market Value (US$ Million) Forecast by Disease Indication, 2017 to 2032

Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Animal Type, 2017 to 2032

Table 30: Middle East and Africa Market Value (US$ Million) Forecast by Distribution Channel Type, 2017 to 2032
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Market Value (US$ Million) by Therapy Type, 2022 to 2032

Figure 02: Global Market Value (US$ Million) by Disease Indication, 2022 to 2032

Figure 03: Global Market Value (US$ Million) by Animal Type, 2022 to 2032

Figure 04: Global Market Value (US$ Million) by Distribution Channel Type, 2022 to 2032

Figure 05: Global Market Value (US$ Million) by Region, 2022 to 2032

Figure 06: Global Market Value (US$ Million) Analysis by Region, 2017 to 2032

Figure 07: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032

Figure 08: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032

Figure 09: Global Market Value (US$ Million) Analysis by Therapy Type, 2017 to 2032

Figure 10: Global Market Value Share (%) and BPS Analysis by Therapy Type, 2022 to 2032

Figure 11: Global Market Y-o-Y Growth (%) Projections by Therapy Type, 2022 to 2032

Figure 12: Global Market Value (US$ Million) Analysis by Disease Indication, 2017 to 2032

Figure 13: Global Market Value Share (%) and BPS Analysis by Disease Indication, 2022 to 2032

Figure 14: Global Market Y-o-Y Growth (%) Projections by Disease Indication, 2022 to 2032

Figure 15: Global Market Value (US$ Million) Analysis by Animal Type, 2017 to 2032

Figure 16: Global Market Value Share (%) and BPS Analysis by Animal Type, 2022 to 2032

Figure 17: Global Market Y-o-Y Growth (%) Projections by Animal Type, 2022 to 2032

Figure 18: Global Market Value (US$ Million) Analysis by Distribution Channel Type, 2017 to 2032

Figure 19: Global Market Value Share (%) and BPS Analysis by Distribution Channel Type, 2022 to 2032

Figure 20: Global Market Y-o-Y Growth (%) Projections by Distribution Channel Type, 2022 to 2032

Figure 21: Global Market Attractiveness by Therapy Type, 2022 to 2032

Figure 22: Global Market Attractiveness by Disease Indication, 2022 to 2032

Figure 23: Global Market Attractiveness by Animal Type, 2022 to 2032

Figure 24: Global Market Attractiveness by Distribution Channel Type, 2022 to 2032

Figure 25: Global Market Attractiveness by Region, 2022 to 2032

Figure 26: North America Market Value (US$ Million) by Therapy Type, 2022 to 2032

Figure 27: North America Market Value (US$ Million) by Disease Indication, 2022 to 2032

Figure 28: North America Market Value (US$ Million) by Animal Type, 2022 to 2032

Figure 29: North America Market Value (US$ Million) by Distribution Channel Type, 2022 to 2032

Figure 30: North America Market Value (US$ Million) by Country, 2022 to 2032

Figure 31: North America Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 34: North America Market Value (US$ Million) Analysis by Therapy Type, 2017 to 2032

Figure 35: North America Market Value Share (%) and BPS Analysis by Therapy Type, 2022 to 2032

Figure 36: North America Market Y-o-Y Growth (%) Projections by Therapy Type, 2022 to 2032

Figure 37: North America Market Value (US$ Million) Analysis by Disease Indication, 2017 to 2032

Figure 38: North America Market Value Share (%) and BPS Analysis by Disease Indication, 2022 to 2032

Figure 39: North America Market Y-o-Y Growth (%) Projections by Disease Indication, 2022 to 2032

Figure 40: North America Market Value (US$ Million) Analysis by Animal Type, 2017 to 2032

Figure 41: North America Market Value Share (%) and BPS Analysis by Animal Type, 2022 to 2032

Figure 42: North America Market Y-o-Y Growth (%) Projections by Animal Type, 2022 to 2032

Figure 43: North America Market Value (US$ Million) Analysis by Distribution Channel Type, 2017 to 2032

Figure 44: North America Market Value Share (%) and BPS Analysis by Distribution Channel Type, 2022 to 2032

Figure 45: North America Market Y-o-Y Growth (%) Projections by Distribution Channel Type, 2022 to 2032

Figure 46: North America Market Attractiveness by Therapy Type, 2022 to 2032

Figure 47: North America Market Attractiveness by Disease Indication, 2022 to 2032

Figure 48: North America Market Attractiveness by Animal Type, 2022 to 2032

Figure 49: North America Market Attractiveness by Distribution Channel Type, 2022 to 2032

Figure 50: North America Market Attractiveness by Country, 2022 to 2032

Figure 51: Latin America Market Value (US$ Million) by Therapy Type, 2022 to 2032

Figure 52: Latin America Market Value (US$ Million) by Disease Indication, 2022 to 2032

Figure 53: Latin America Market Value (US$ Million) by Animal Type, 2022 to 2032

Figure 54: Latin America Market Value (US$ Million) by Distribution Channel Type, 2022 to 2032

Figure 55: Latin America Market Value (US$ Million) by Country, 2022 to 2032

Figure 56: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 59: Latin America Market Value (US$ Million) Analysis by Therapy Type, 2017 to 2032

Figure 60: Latin America Market Value Share (%) and BPS Analysis by Therapy Type, 2022 to 2032

Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Therapy Type, 2022 to 2032

Figure 62: Latin America Market Value (US$ Million) Analysis by Disease Indication, 2017 to 2032

Figure 63: Latin America Market Value Share (%) and BPS Analysis by Disease Indication, 2022 to 2032

Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Disease Indication, 2022 to 2032

Figure 65: Latin America Market Value (US$ Million) Analysis by Animal Type, 2017 to 2032

Figure 66: Latin America Market Value Share (%) and BPS Analysis by Animal Type, 2022 to 2032

Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Animal Type, 2022 to 2032

Figure 68: Latin America Market Value (US$ Million) Analysis by Distribution Channel Type, 2017 to 2032

Figure 69: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel Type, 2022 to 2032

Figure 70: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel Type, 2022 to 2032

Figure 71: Latin America Market Attractiveness by Therapy Type, 2022 to 2032

Figure 72: Latin America Market Attractiveness by Disease Indication, 2022 to 2032

Figure 73: Latin America Market Attractiveness by Animal Type, 2022 to 2032

Figure 74: Latin America Market Attractiveness by Distribution Channel Type, 2022 to 2032

Figure 75: Latin America Market Attractiveness by Country, 2022 to 2032

Figure 76: Europe Market Value (US$ Million) by Therapy Type, 2022 to 2032

Figure 77: Europe Market Value (US$ Million) by Disease Indication, 2022 to 2032

Figure 78: Europe Market Value (US$ Million) by Animal Type, 2022 to 2032

Figure 79: Europe Market Value (US$ Million) by Distribution Channel Type, 2022 to 2032

Figure 80: Europe Market Value (US$ Million) by Country, 2022 to 2032

Figure 81: Europe Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 84: Europe Market Value (US$ Million) Analysis by Therapy Type, 2017 to 2032

Figure 85: Europe Market Value Share (%) and BPS Analysis by Therapy Type, 2022 to 2032

Figure 86: Europe Market Y-o-Y Growth (%) Projections by Therapy Type, 2022 to 2032

Figure 87: Europe Market Value (US$ Million) Analysis by Disease Indication, 2017 to 2032

Figure 88: Europe Market Value Share (%) and BPS Analysis by Disease Indication, 2022 to 2032

Figure 89: Europe Market Y-o-Y Growth (%) Projections by Disease Indication, 2022 to 2032

Figure 90: Europe Market Value (US$ Million) Analysis by Animal Type, 2017 to 2032

Figure 91: Europe Market Value Share (%) and BPS Analysis by Animal Type, 2022 to 2032

Figure 92: Europe Market Y-o-Y Growth (%) Projections by Animal Type, 2022 to 2032

Figure 93: Europe Market Value (US$ Million) Analysis by Distribution Channel Type, 2017 to 2032

Figure 94: Europe Market Value Share (%) and BPS Analysis by Distribution Channel Type, 2022 to 2032

Figure 95: Europe Market Y-o-Y Growth (%) Projections by Distribution Channel Type, 2022 to 2032

Figure 96: Europe Market Attractiveness by Therapy Type, 2022 to 2032

Figure 97: Europe Market Attractiveness by Disease Indication, 2022 to 2032

Figure 98: Europe Market Attractiveness by Animal Type, 2022 to 2032

Figure 99: Europe Market Attractiveness by Distribution Channel Type, 2022 to 2032

Figure 100: Europe Market Attractiveness by Country, 2022 to 2032

Figure 101: Asia Pacific Market Value (US$ Million) by Therapy Type, 2022 to 2032

Figure 102: Asia Pacific Market Value (US$ Million) by Disease Indication, 2022 to 2032

Figure 103: Asia Pacific Market Value (US$ Million) by Animal Type, 2022 to 2032

Figure 104: Asia Pacific Market Value (US$ Million) by Distribution Channel Type, 2022 to 2032

Figure 105: Asia Pacific Market Value (US$ Million) by Country, 2022 to 2032

Figure 106: Asia Pacific Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 107: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 108: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 109: Asia Pacific Market Value (US$ Million) Analysis by Therapy Type, 2017 to 2032

Figure 110: Asia Pacific Market Value Share (%) and BPS Analysis by Therapy Type, 2022 to 2032

Figure 111: Asia Pacific Market Y-o-Y Growth (%) Projections by Therapy Type, 2022 to 2032

Figure 112: Asia Pacific Market Value (US$ Million) Analysis by Disease Indication, 2017 to 2032

Figure 113: Asia Pacific Market Value Share (%) and BPS Analysis by Disease Indication, 2022 to 2032

Figure 114: Asia Pacific Market Y-o-Y Growth (%) Projections by Disease Indication, 2022 to 2032

Figure 115: Asia Pacific Market Value (US$ Million) Analysis by Animal Type, 2017 to 2032

Figure 116: Asia Pacific Market Value Share (%) and BPS Analysis by Animal Type, 2022 to 2032

Figure 117: Asia Pacific Market Y-o-Y Growth (%) Projections by Animal Type, 2022 to 2032

Figure 118: Asia Pacific Market Value (US$ Million) Analysis by Distribution Channel Type, 2017 to 2032

Figure 119: Asia Pacific Market Value Share (%) and BPS Analysis by Distribution Channel Type, 2022 to 2032

Figure 120: Asia Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel Type, 2022 to 2032

Figure 121: Asia Pacific Market Attractiveness by Therapy Type, 2022 to 2032

Figure 122: Asia Pacific Market Attractiveness by Disease Indication, 2022 to 2032

Figure 123: Asia Pacific Market Attractiveness by Animal Type, 2022 to 2032

Figure 124: Asia Pacific Market Attractiveness by Distribution Channel Type, 2022 to 2032

Figure 125: Asia Pacific Market Attractiveness by Country, 2022 to 2032

Figure 126: Middle East and Africa Market Value (US$ Million) by Therapy Type, 2022 to 2032

Figure 127: Middle East and Africa Market Value (US$ Million) by Disease Indication, 2022 to 2032

Figure 128: Middle East and Africa Market Value (US$ Million) by Animal Type, 2022 to 2032

Figure 129: Middle East and Africa Market Value (US$ Million) by Distribution Channel Type, 2022 to 2032

Figure 130: Middle East and Africa Market Value (US$ Million) by Country, 2022 to 2032

Figure 131: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 132: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 133: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 134: Middle East and Africa Market Value (US$ Million) Analysis by Therapy Type, 2017 to 2032

Figure 135: Middle East and Africa Market Value Share (%) and BPS Analysis by Therapy Type, 2022 to 2032

Figure 136: Middle East and Africa Market Y-o-Y Growth (%) Projections by Therapy Type, 2022 to 2032

Figure 137: Middle East and Africa Market Value (US$ Million) Analysis by Disease Indication, 2017 to 2032

Figure 138: Middle East and Africa Market Value Share (%) and BPS Analysis by Disease Indication, 2022 to 2032

Figure 139: Middle East and Africa Market Y-o-Y Growth (%) Projections by Disease Indication, 2022 to 2032

Figure 140: Middle East and Africa Market Value (US$ Million) Analysis by Animal Type, 2017 to 2032

Figure 141: Middle East and Africa Market Value Share (%) and BPS Analysis by Animal Type, 2022 to 2032

Figure 142: Middle East and Africa Market Y-o-Y Growth (%) Projections by Animal Type, 2022 to 2032

Figure 143: Middle East and Africa Market Value (US$ Million) Analysis by Distribution Channel Type, 2017 to 2032

Figure 144: Middle East and Africa Market Value Share (%) and BPS Analysis by Distribution Channel Type, 2022 to 2032

Figure 145: Middle East and Africa Market Y-o-Y Growth (%) Projections by Distribution Channel Type, 2022 to 2032

Figure 146: Middle East and Africa Market Attractiveness by Therapy Type, 2022 to 2032

Figure 147: Middle East and Africa Market Attractiveness by Disease Indication, 2022 to 2032

Figure 148: Middle East and Africa Market Attractiveness by Animal Type, 2022 to 2032

Figure 149: Middle East and Africa Market Attractiveness by Distribution Channel Type, 2022 to 2032

Figure 150: Middle East and Africa Market Attractiveness by Country, 2022 to 2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Veterinary Respiratory Disease Treatment Market

Published : December 2016

Healthcare

Veterinary Pain Management Drugs Market

Published : December 2016

Healthcare

Veterinary Biologics Market

Published : March 2022

Healthcare

Veterinary Vaccines Market

Published : February 2022

Google translate

Veterinary Auto-Immune Therapeutics Market